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Introduction
Abdominal aortic aneurysms (AAAs) are classically 
asymptotic localized enlargements of the infrarenal ab-
dominal aorta that result primarily from an altered depo-
sition and degradation of extracellular matrix. A cata-
strophic endpoint in the natural history of AAAs is 
rupture – an event with a high mortality rate. Unfortu-
nately, current clinical capabilities for predicting rupture 
remain wanting, and clinical interventions continue to be 
based primarily on the maximum diameter or rate of en-
largement of the lesion. Yet, many small lesions rupture 
while larger lesions do not [1,2], and many AAAs do not 
enlarge continuously. That is, radial enlargement of ane-
urysm often occurs via stepwise dilatations, with periods 
of stability alternating with periods of enlargement [3]. 
One possible reason for this variability in clinical outco-
mes is intraluminal thrombus (ILT). A large populati-
on-based study showed that all AAAs larger than 6 cm 
contain ILT, as do a majority of smaller lesions [4]. Such 
thrombi are typically layered structures that, unlike other 
blood clots, show few signs of healing. The portion of 
ILT closest to the flowing blood (i.e., the luminal layer) 
is characterized by an aggregation of activated platelets 
as well as the entrapment of erythrocytes (RBCs) and 
leukocytes within an evolving fibrin mesh that appears 
to remodel continuously. This layer is usually ~2 mm 
thick [5], which may be limited by the depth to which 
blood components can penetrate the fibrin mesh. Leuko-
cytes within the luminal layer produce enzymes (e.g., 
matrix metalloproteinases (MMPs) and neutrophil ela-
stase) that degrade the aortic wall or activate those that 
do (e.g., by activating urokinase plasminogen activator 
(uPA), which increases plasmin which activates latent 
MMPs). In contrast, the degradation of fibrin tends to 
outpace its deposition in the deeper layers of thick 
thrombi, often referred to as medial (middle) and ablu-
minal (next to the aneurysmal wall). These deeper layers 
are also mostly devoid of cells [6]. The lack of platelets 
in these layers suggests little production of fibrin, hence 
degradation of fibrin likely dominates deposition within 
these layers. Whereas the biochemically active luminal 
layer can disrupt underlying wall structure, and thereby 
promote rupture of an AAA, most ILTs are much thicker 
than 2 mm. In these cases, the ILT may stress shield 
the wall mechanically [7] and may serve as a barrier to 
the diffusion of oxygen and proteases coming from the 
blood and luminal ILT. It is thus important to account 
for the complex and diverse biomechanical and bio-
chemical roles of ILT when modelling AAA biomecha-
nics [8].
Thrombus was ignored in AAA modelling until 1993, 
when Inzoli et al. [9] suggested that an ILT might mec-
hanically shield the aortic wall and thereby decrease the 
peak wall stress and associated rupture risk. Despite 
overwhelming evidence that ILT is biochemically active 
[6,10], it has been either modelled as an inert, homoge-
neous material in static models that focus on the state of 
stress in the wall (e.g., [7]) or neglected in most G&R 
studies (e.g., [11,12]). Clearly, proteolysis could contri-
bute to the chronic inflammation characteristic of AAAs. 
There is, therefore, a pressing need for greater understan-
ding. The goal of this research was to develop a mathe-
matically tractable, first generation G&R model of en-
largement and possible rupture of thrombus-laden AAAs, 
including a framework for quantifying and predicting 
interrelationships between the biochemistry and biome-
chanics. Additionally, we examined potential differences 
in model predictions for physiological ranges of parame-
ter values. We investigated the possible extent to which 
these parameters influence AAA evolution and to reco-
gnize the key features of the thrombus-laden model effe-
cts of commonly proposed factors that influence the risk 
of rupture. Thus, this study also provides some insight 
into possible roles of common risk factors on the natural 
history of AAAs.
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Methods
We build on the model presented in [17], but for com-
pleteness we apply the salient equations here. We assu-
med that AAAs initiate from aged non-aneurysmal aor-
tas and focused on an idealized cylindrical geometry to 
highlight emergent effects of differences in the values of 
the constitutive parameters. Although this 1D model thus 
considers mechanical changes and chemical diffusion in 
the radial direction alone, we submit that the associated 
predictions provide vital insight into the importance and 
interrelationship of many parameters in the model befo-
re including the additional complexities and significantly 
increased computational expenses of analyzing 3D geo-
metries. Ultimately, careful attention and refinement, as 
these complex G&R models are developed, will increa-
se the likelihood of an accurate understanding and simu-
lation of patient-specific lesions, and can guide experi-
mental efforts to understand, predict, and therapeutically 
address the roles of ILT in AAA progression.
Kinematics of AAA
We use the notation of Karšaj and Humphrey [10]. Brie-
fly, individual constituents k deposited at a generic G&R 
time   are incorporated within extant extracellular ma-
trix with pre-stretch Gk ( ) , whereas the mapping of 
differential position vectors defined in individual natural 
configurations for each constituent produced at time   
to those in a current (deformed) mixture configuration 
at time s is captured by deformation gradient Fn
k s( ) ( )  
(cf. Figure 1 in [10]). The right Cauchy-Green tensor 
Cn
k s( ) ( )  is thus ... Similarly, for the overall deformation 
gradient for the mixture F , the associated right Cau-
chy-Green tensor is C F F T .
Kinetics of AAA
Following [17], elastin is not produced in maturity; hen-
ce, it can only degrade as the model progresses in time. 
In contrast, collagen and smooth muscle undergo turno-
ver in the wall as does fibrin in the thrombus. Such tur-
nover implies both degradation and deposition, the latter 
at production rate. Whereas deposition is constant at a 
basal production rate mB
k  during homeostasis, it may be 
altered in response to deviations in intramural stress 
from a homeostatic value th
k  due to injury, disease, or 
inflammation. We let the current mass of each consti-
tuent k evolve as
 M s M Q s m q sk k k k k
s
( ) ( ) ( ) ( )= + ( ) −∫0
0
 τ τ τ d   (1)
where q sk ( )−τ  is survival function defining the per-
centage of constituent produced at past time   that re-
mains at current time s  with a special case that
Q s q sk k( ) ( )= −0 . Given that M k ( )0  is the initial mass 
of constituent k, note that M s M Q se e e( ) ( ) ( ) 0  for ela-
stin since we assume no production in maturity.
We further let the survival function qk  depend on the 
rate-type removal parameter Kq
k , where
 q s K Q sk q
k
s






⋅ ( )∫τ τ τ
τ
exp , d ,  (2)
with Q sk e, ( )=1  for all constituents except muscle. To 
model anoikis of smooth muscle cells (i.e., apoptosis 
caused by a loss of attachment to surrounding matrix, 
including elastic fibers), the degradation of smooth 
muscle was linked to the degradation of elastin by
Q s Q sSMC e e, ( )= ( ) .
Intraluminal thrombus
Understanding of the spatially evolving deposition of 
thrombus remains wanting; however, many medical ima-
ges of large AAAs suggest that the overall luminal dia-
meter tends to be maintained. We therefore assumed that 
the luminal area remained constant throughout our simu-
lations, meaning that additional ILT was deposited in 
every time step in which the lesion enlarged, often 
burying prior portions of the luminal layer which then 
became medial and abluminal layers (cf. [16] for the 
naming convention of ILTs. Moreover, based on experi-
mental findings ([18]), we considered fibrin, fibrin de-
gradation products (FDPs), erythrocytes (RBCs) and 
voids to be the most significant space-filling constituents 
of a layered ILT. Even though leukocytes, platelets and 
non-collagenous extracellular proteins were neglected as 
load-bearing constituents, they were nevertheless crucial 
for the biological activity of the thrombus.
Fibrin. During coagulation platelets release thrombin, 
which helps to convert soluble fibrinogen into fibrin 
that, in turn, polymerizes to form a cross-linked mesh. 
We modelled changes in the mass of fibrin similar to 
changes in wall constituents (eq. (1)), but assumed that 
the production rate of fibrin depended on the mass 
of platelets Mi
plt  and decreased with increasing fibrin 
density i
f  through correlation parameter Kplt
f
, , such 
that







f( ) ( ) ( ),τ τ φ τφ= −( )1  (3)
Fibrin is dissolved by plasmin. Moreover, since fibrino-
lysis has been reported to be inversely proportional to 
the density of the fibrin mesh and its current stretch [19], 
we considered the mass removal rate-type parameter for 
fibrin of the form (cf. )
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where kq
f  is homeostatic value depending on the natural 
half-life of fibrin, Mi
pls  is mass of plasmin, and i  is 
fibrin stretch; wq
f  is weighting function.
Cells and Platelets.
The majority of blood-derived cells within an ILT reside 
in the luminal layer ([5,20]), presumably because flowing 
blood can replenish and sustain cells only to a certain 
depth. Thus, we defined the boundary of the luminal 
layer by a depth beyond which cells could not be reple-
nished, either because a critical fibrin mesh density 
crit
f RBC,  was reached or because a critical radius rcrit τ( )  
was attained. This critical radius was defined in each 
instant by a critical mass of fibrin Mcrit
f , such that







( , )τ∑ = ,  (5)
where Mi
f  is mass of fibrin in layer i. The quantity of 
blood-borne cells in the luminal layer depended on the-
ir luminal concentration (e.g. Ml
plt  for platelets). We 
assumed the first order decay process for cells that be-
came buried in the medial layer (with a half-life 1 2/
plt  of 
7 to 11 days for platelets and τ1 2 120/
RBC=  days for eryt-
hrocytes). In summary, the mass of platelets (and simi-
larly for leukocytes, primarily neutrophils,Mi
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where crit
i,1  is the time at which a critical mass of fibrin 
(i.e., rcrit ) was achieved, thus transitioning the layer 
from luminal to medial. Similarly, crit
i,2  represents the 
time at which the limit of the luminal layer was achieved 
by reaching the critical mass fraction of fibrin (i.e., mesh 
density). Leukocytes were assumed not to contribute si-
gnificantly to the volume of the ILT; nonetheless, their 
presence is important for biochemical activity (e.g., pro-
duction of plasmin, MMPs or other elastases).The distri-
bution of erythrocytes within the ILT was defined simi-
larly, with the exception of using a mass fraction 
necessary to calculate the overall stored energy of ILT 
instead of the mass.
Plasmin, EDPs, and neovascularization.
Conversion of plasminogen to plasmin is a complex pro-
cess catalyzed by multiple enzymes, including a key step 
by either tissue plasminogen activator (tPA, found on 
endothelial cells) or urokinase plasminogen activator 
(uPA, coming mainly from the blood stream via mesen-
chymal and inflammatory cells). Conversely, activation 
may be inhibited by plasmin activation inhibitor (PAI-1) 
and alpha-2 antiplasmin. For this simplified model, 
we sought to capture phenomenologically the overall 
 increase in activated plasmin and to model its diffusion 
from two primary sources: the leukocyte-rich luminal 
layer of the ILT and the inflamed aneurysmal wall (to 
which leukocytes invade via the vasa vasorum). This 
increased production of plasmin within the wall is con-
sistent with immunohistological reports [21]. The mass 
of activated plasmin Mi
pls  that degrades fibrin is given 
as























pls  is correlation factor between plasmin and 
neutrophils in the thrombus, K f
pls  is the amount of 
 plasmin consumed per unit of fibrin, and Mwall
pls ( )  
is the mass of plasmin in the wall, calculated as









VV( ) ( ) ( )τ τ τ= + . We assumed 
that the plasmin generated within the wall largely de-
pends on the total mass of elastin degradation products 
Mtot
EDP , which are chemo-attractants for inflammatory 
cells and stimulate neovascularization of the wall (i.e., 
increase the area of vasa vasorum Atot
VV , [22]). Correla-
tions between plasmin and EDPs/vasa vasorum were 
accounted for by KEDP
pls  and KVV
pls , respectively. The pro-
duction rate of EDPs directly depended on the amount 
of elastin degraded per time step, while their degradation 
was modelled as the first-order decay with constant 
half-life. The total mass of EDPs can then be calculated 
by eq. (1).
Due to the controversial influence of hypoxia on neovas-
cularisation, the studies that showed EDPs alone promo-
te neovascularization [22], we modelled the develop-
ment of vasa vasorum solely as a function of the mass 
of EDPs, such that









 dτ ,  (8)
where AVV0  is the area of vasa vasorum in healthy aorta, 
and KEDP
VV  is the correlation factor that relates vasa va-
sorum growth per unit of EDPs per unit time.
Fibrin degradation products and voids.
The luminal layer contains entrapped erythrocytes wit-
hin a thick fibrin mesh. Once the luminal layer is buried 
deeper within the thrombus, erythrocytes cannot be re-
plenished. Likewise, the amount of platelets necessary 
for fibrin deposition decreases steeply, thus allowing 
degradation to outpace deposition. Dissolution of fibrin 
and apoptosis of red blood cells can leave small inter-
connected channels (“voids” or “canaliculi”) throughout 
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the ILT [5]. We assumed that degrading fibrin was con-
verted partly into fibrin degradation products (FDPs) and 
partly into canaliculi (as fibrin was removed by macrop-
hages) in a 7:3 ratio.
Biochemical interaction of ILT and aneurysmal 
wall
Effects of the proteolytically active luminal layer were 
integrated via additional terms in the mass removal ra-
te-type parameter Kq
k  in eq. (2). For example, the elastin 
in normally aging aorta depends solely on its natural 
half-life 1 2/
e  on the order of forty to fifty years: 
K ke q
e e= = ( )ln /2 1 2τ . Increased degradation of elastin 
in an aneurysm due to inflammation was incorporated 
via an additional term,





e elas( ) ( , ),τ τ= + ,  (9)




Correspondingly for collagen, we let (cf. [10])
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where the collagen mass removal parameter Kq
c  de-
pends on the ratio of the current (∂ ∂ ( )W
c
n
cF τ ) to the 
homeostatic (∂ ∂ ( )W
c
n
cF 0 ) tension, and kq
c  is the rate-ty-
pe removal parameter associated with homeostatic 
half-life; the additional terms relate to the distribution of 
active MMPs (i.e., collagenases). Similar to plasmin, 
MMPs may arise from two sources: luminal layer in 
ILT or vasa vasorum in the aortic wall. The first approxi-
mation, quasi-static transport, was determined easily 









where D  is the diffusion coefficient that can be esti-
mated based on the available data of the radial distribu-
tion of proteases [15,20]. We defined the available ela-
stase/MMPs from the luminal layer, K MN
elas
tot




N  for MMPs), where KN
elas MMP/  described how 
much elastase/MMP was produced per unit of leukocytes 
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similar to the center of mass. The concentration of ela-
stase/MMPs available at the outer radius depended on 
the area of vasa vasorum and number of inflammatory 







VV( ) ( ) . Thus, by solving 
the diffusion equation, the overall distribution of prote-
ases was:
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where k  indicates elastases or collagenases. Mass of 
inflammatory cells in the wall, Mtot
WBC , was modelled 
similar to  with degradation depending on cellular half-li-
fe, and production mtot
WBC  increasing with the growth of 



























,  is the correlation factor that relates pro-
liferation of white blood cells with EDPs and neovascu-
larisation, and   is power parameter.
Stress analysis
The Cauchy stress within the aortic wall was calculated 












tT active θ θ ,  (14)
with W Wk
k
=∑  the overall stored energy function, and 
tactive  the active stress contribution from circumferentia-
lly oriented smooth muscle contractility. Similar to Va-
lentín et al. [23], phenotypic transitioning of smooth 
muscle cells from a contractile to synthetic state is con-
sidered by allowing the decreasing maximal active stre-
ss Tm  such that T s T Q sm m m m e( )= ( )⋅ + −( ) ( )( )0 1β β .
By noting that fibers deposited into extant matrix at di-
fferent times have different deformation gradients, the 
total stored energy of the constituent is the combination 
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For the inherent stored-energy form of each type of the 
constituent ( ˆ kW ), isotropic elastin is modelled as 
neo-Hookean, while collagen and smooth muscle are 
modelled as fiber-like with an exponential constitutive 
response in tension but no compressive stiffness, as in 
[17].
Mechanically, ILT can bear stress and possibly reduce 
peak wall stress. Cauchy stress in the ILT was modelled 
using the stored energy function for an isotropic fibrin 
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mesh based on [18], and the neo-Hookean strain energy 
function was used for the FDPs.
Prediction of Aaa Progression Based on Risk 
Factors
The ultimate goal of computational modelling of aneu-
rysmal G&R is to help clinicians predict rupture risk. 
Although multiple potential risk factors of AAA rupture 
have been suggested [24], we consider herein a few key 
factors within the limitations of our model. Note that 
rupture herein was defined as any normal component of 
wall stress reaching 460 kPa [25].
Smoking
Smoking has been linked to multiple vascular diseases. 
Among many other effects, it elevates oxidative stress, 
injures arterial endothelium, and promotes atherogenesis 
[26]. It increases the oxidation of low density lipoprote-
ins, which promotes monocyte adhesion and migration 
into the subintimal space and thereby increases recrui-
tment of inflammatory cells in the vascular wall [27]. 
Smoking also increases the concentration of plasma fi-
brinogen and alters the activity of platelets, thus poten-
tiating thrombosis along dysfunctional endothelium 
[27]. Finally, it correlates strongly with increased aortic 
blood pressure, heart rate, and arterial stiffness [28]. It 
has been suggested further that smoking-induced arterial 
stiffening is isotropic, as reflected by a consistent incre-
ase in an elastin-associated parameter [29].
Many studies associate smoking with larger AAAs [3,30] 
and expansion rates [31]. Some studies suggest that ce-
ssation of smoking may inhibit aneurysmal expansion, 
even though two years of cessation does not reduce ar-
terial stiffness [32]; indeed, it can take up to a decade to 
reduce stiffness to the level of never-smokers [33]. Si-
milarly, five years of abstinence can reduce fibrinogen 
concentrations to the range of never-smokers [34].
Motivated by these studies, we investigated the natural 
histories of aneurysms in simulated smokers, ex-smo-
kers, and those who had never smoked. Smoking was 
modelled by an increased elastin stiffness, inflammation, 
and platelet activity. Endothelial and smooth muscle cell 
dysfunctions are characteristic of aneurysms indepen-
dent of smoking and were implicitly included in the mo-
del for both smokers and non-smokers. For smoking 
cessation, we assumed a linear decrease over 10 years in 
the smoking-induced increase in elastin stiffness and li-
near decrease over 5 years in inflammation to the ne-
ver-smoker level. All other G&R parameters were iden-
tical among the groups.
After 20 years the simulated AAA diameter was greater 
for smokers (5.39 cm) than non-smokers (4.40 cm) with 
an associated average increase in the dilatation rate of 
0.0495 cm/year compared with non-smokers (Figure 1). 
These results are consistent with clinical observations. 
Bhak et al. [30] reported that smoking was associated 
with a 0.05±0.01 cm/year increase in the linear expansi-
on rate. A comparison of AAAs in smokers and non-smo-
kers to aneurysms simulated with only increases in ela-
stin stiffness or increases in both elastin stiffness and 
inflammation suggest that inflammation played the gre-
atest role early in aneurysmal progression, though incre-
ased stiffness alone could lead to large aneurysms over 
time (Figure 1). Increased plasma fibrinogen concentra-
tion and platelet activity (present in the smoker group 
but not in the group with only elastin stiffness and in-
flammation) did not have a significant influence on AAA 
evolution (dotted vs. dashed line). There was only a sli-
ght decrease in the AAA size due to the increased pro-
duction of fibrin through higher platelet activity, which 
resulted in a slightly stiffer, thinner luminal layer. Note 
that this does not mean that an increased platelet activi-
ty could potentially stabilize AAAs since platelets are 
chemotactic for neutrophils and monocytes [35] and can 
cause higher inflammation and expansion rates.
Changes in rates of dilatation after smoking cessation 
have not been studied well, though there is some eviden-
ce of a slow (perhaps non-significant) decline in dilata-
tion and risk of aneurysm development after cessation 
of smoking [36]. Thus, consistent with general public 
health guidelines, the immediate cessation of smoking is 
recommended, preferably before AAA development.
Fig. 1. Simulated evolution of an AAA in a non-smoker (solid 
line), in cases of increased elastin stiffness (dash-dotted line), 
 increased elastin stiffness plus elevated inflammation (dotted 
line), and increased elastin stiffness, higher inflammation, and 
increased platelet activity (dashed line) – that is, full effects of 
smoking.
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Aneurysm stabilization factors
Numerous studies have proposed various anti-inflamma-
tory drugs for reducing or arresting the enlargement of 
AAAs, some of which act directly on MMPs [37,38] 
while others reduce inflammation indirectly (e.g., by pla-
telet inhibitors [39,40] or immunosuppressive agents 
[41]). Another study in mice [37] suggested the impor-
tance of preserving medial elastin in order to attenuate 
aneurysmal dilatation. Although animal models have 
yielded conflicting results on roles of MMP inhibition or 
altering transforming growth factor TGF-β signaling on 
AAA expansion, some results have been encouraging. 
Nevertheless, non-specific MMP inhibition has not been 
found to reduce aneurysm progression in human patients 
[42]. Clearly, there is a need for increased understanding 
of the biochemical mechanisms of aneurysm formation 
and evolution.
Figure 2 shows that our thrombus-laden aneurysm model 
supports results from [37], where the inhibition of ela-
stase (i.e., a slower degradation of elastin) helped to pre-
vent rupture, and to some extent lead towards stabilizing 
the aneurysm, independent of collagen stiffness.
Other studies focused on the specific or non-specific in-
hibition of collagenases, which in most animal models 
led to stabilization. Similarly, the current model suggests 
that high rates of collagen degradation can lead to a pro-
gressive enlargement (solid line in Figure 3), though 
reduced inflammation could perhaps prevent a rupture 
(dashed line in Figure 3). Thus, the current results sug-
gest that degradation rates of both elastin and collagen 
(i.e., concentrations of proteases, controlled for example 
by parameters wq elas
e
,  and wq elas
MMP
,  in eq. (9)) may strongly 
influence aneurysmal progression.
Gender and age
Gender differences have been identified in cardiovascu-
lar aging and in the evolution, management, and respon-
se to treatment for many cardiovascular diseases, inclu-
ding AAAs [43]. For example, females have stiffer large 
arteries in pre-puberty, but more compliant ones in 
post-puberty [44]. Additionally, age-associated endothe-
lial function declines in men years before women [45]. 
These findings, among many others, could contribute to 
the increased prevalence of AAAs in men compared to 
women [46]. Yet, males have a 3-4 times lower risk of 
rupture than females [43], possibly due to higher stren-
gth of the AAA wall [47]. Similarly, noting that males 
have stiffer arteries on average [48], previous G&R mo-
dels suggested that increased material stiffness of colla-
gen decreases the likelihood of rupture.
Beyond biological sex, age may also play a role in AAA 
progression. Wilson et al. [12] demonstrated in a G&R 
model that initial aortic properties may strongly influen-
ce AAA progression. Such properties are likely depen-
dent on a patient’s biological age (i.e., genetics, smoking 
status, comorbidities, exercise, etc.) as opposed to chro-
nological age. For example, the observation that females 
who undergo open surgical repair for AAA are signifi-
cantly older compared to males [48] may be reflective 
of their “younger” biological status as aforementioned 
in their later decline of endothelial function. Therefore, 
we explored differences in AAA expansion in males and 
females. The gender difference was modelled by diffe-
rent collagen stiffness (collagen in males stiffens, whe-
reas in females collagen stiffness remains constant) and 
different initial structure of aorta. Formation of aneu-
Fig. 2. Simulated AAA evolution (a) and corresponding degrada-
tion of elastin (b) in cases of rapid versus slow elastin degradati-
on. Note that the aneurysm was initiated by degrading 5% of 
elastin. Rupture is denoted by “x”.
Fig. 3. Simulated AAA evolution (a) and associated dilatation 
rates (b) for different rates of collagen degradation in case of 
stiffening of collagen. “x” denotes rupture.
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rysm at a younger age, possibly typical for men, was 
taken into account by higher amounts of elastin (33.6% 
in younger vs. 27.4% in older), and a thinner intima (4% 
vs. 16%). Additionally, elastin in younger patients is less 
pre-stretched compared to older (1.3 in younger vs. 1.4 
in older).
Similar to the results for the development of hypertensi-
on before AAA aneurysms developed on a stiffer aortic 
wall led to smaller expansion rates, with less likelihood 
of rupture (Figure 4).With regards to age, a younger aor-
tic wall was more compliant and underwent larger de-
formations (whether ruptured or unruptured). It also had 
higher amounts of elastin, whose preservation is sugge-
sted to prevent rupture (see section 3.2). Therefore, the 
age at which an aneurysm develops might have an im-
portant impact on AAA evolution and might be an addi-
tional factor contributing to a high rupture risk in fema-
les.
Hypertension
Hypertension has been suggested as a key factor in dri-
ving AAA expansion [30] and rupture-risk, particularly 
in aneurysms smaller than 5.5 cm [49]. Hypertension 
leads to progressive changes in vascular structure, stif-
fness, thickness, radial dilatation and axial lengthening 
[50], all of which are G&R responses. To evaluate the 
effect of hypertension on AAA progression, we conside-
red two cases: patients who were hypertensive before 
development of an AAA and patients who developed 
hypertension during the progression of the lesion. In the 
former case, computational results suggested that aneu-
rysms originating from a hypertensive wall (simulated 
starting from healthy, non-hypertensive aorta) tend to 
rupture or stabilize at smaller sizes (Figure 5 (a)), depen-
ding on the properties of collagen.
When hypertension developed during aneurysmal pro-
gression, the luminal radius changed under the altered 
load. Thus, the luminal area was allowed to dilate to 
the size of an equivalent hypertensive, non-aneurysmal 
aorta. We considered three stages of hypertension [51] 
defined as increases in mean blood pressure of 40% (36 
mmHg), 60% (54 mmHg), and 80% (72 mmHg).
As expected, a greater increase in blood pressure resul-
ted in a larger diameter (Figure 6). The average increase 
in expansion rate of a hypertensive aneurysm over 15 
years was 0.0235, 0.0228 and 0.0221 cm/year per 10 
mmHg increase for stages 1, 2 and 3, respectively. This 
is in good accordance with clinical observations of 0.02 
±0.01 cm/year per 10 mmHg [30]. Interestingly, compu-
tational results also suggested that a later development 
of hypertension is more likely to lead to rupture even 
though earlier hypertension leads to larger AAAs (Figure 
7). This finding highlights the importance of G&R com-
pensation as it is not strictly the diameter that determines 
rupture but the failure of a system to adequately com-
pensate to a perturbation (i.e., dilatation need not mean 
decompensation). In this case, a relatively healthier wall 
Fig. 4. Simulated evolution of AAAs for males and females of 
varying age. “x” denotes rupture.
Fig. 5. Evolution of AAA diameter (a) and expansion rate (b) from 
a hypertensive aorta. Solid lines represent dilatation for constant 
collagen material properties; dashed lines represent enlargement 
during collagen stiffening.
Fig. 6. Evolution of AAAs arising from a healthy aorta after re-
taining normal blood pressure (solid), or spontaneously develo-
ping stage 1 (dashed), stage 2 (dash-dotted), or stage 3 hyperten-
sion (dotted).
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(i.e., earlier in AAA development) was better able to 
compensate for higher blood pressure than was the wall 
exposed to the same pressure after being more extensi-
vely damaged as the AAA progressed.
Thickness of intraluminal thrombus
Another potential risk factor that has garnered increased 
attention is the size of the ILT. Different measures of ILT 
size, including thrombus thickness [52], volume [53], 
and relative cross-sectional area [3] were correlated with 
rapid expansion or rupture. Yet other studies suggest that 
ILT volume is the same in ruptured and intact AAAs 
[54], and case reports of unruptured giant thrombus-la-
den aneurysms (e.g., 25 cm in [55]) were described. Be-
cause of the cylindrical geometry used herein, it was not 
possible to consider whether rupture risk is linked to ILT 
volume or area. Nevertheless, we note that the distribu-
tion of proteases (M elas  for elastase andMMMP  for 
collagenase) in this 1D model depends on both the ava-
ilable proteases from each source (luminal layer of the 
ILT and vasa vasorum in the aortic wall) and the distan-
ce between the two sources; hence, it is related directly 
to ILT thickness.
The amount of available proteases in the luminal layer 
varies significantly among patients, from virtually non-
existent to very high (e.g., see measured MMP-9 activi-
ty in both thrombus and wall specimens from 35 patients 
in Figure 2 in [21]). Thus, we investigated the possible 
evolution of an AAA for different amounts of protease 
activity in the ILT (by increasing K M sN
k
tot
N ( )  in eq. (12)). 
Figure 8 shows differences in predicted AAA enlarge-
ment in cases wherein the ILT and vasa vasorum have 
equal proteolytic activity ((a)-(c)) or the ILT is an order 
of magnitude more active ((d)-(f)). In the latter case, the 
proteolytic activity in the wall increased sharply as long 
as the luminal layer was directly attached to the aneu-
rysmal wall (i.e., while the solid and dashed lines in 
Figure 8 (a) coincide), thus resulting in rapid expansion 
of the aneurysm. As the less proteolytically active deeper 
layers form and act as a barrier to protease diffusion, 
proteolytic activity decreased abruptly and the expansion 
rate declined (Figure 8 (c) and (f)).
Interestingly, higher activity within the luminal layer led 
to a greater reduction in the expansion rate once the lu-
minal layer was displaced from the wall, even causing a 
temporary near cessation of expansion (Figure 8 (f)). 
Several studies (e.g. [2]) report that the majority of 
AAAs dilate discontinuously with periods of expansion 
alternating with periods of quiescence. Though the exa-
ct cause of this phenomenon has not been determined, 
the current results suggest that ILT, specifically altering 
the proximity of the biologically active luminal layer 
from the wall, may directly influence expansion rates 
and thus play a role in determining clinical outcomes. 
Although only one cycle of expansion and arrest is 
allowed in this axisymmetric cylindrical geometry, 
expanding this model to 3D patient-specific geometries 
will allow further testing of the relationship of ILT, dis-
continuous expansion, and patient-specific outcomes by 
exploring more complex expansion patterns due to ec-
centric deposition of thrombus (i.e. where one portion of 
the ILT remains thinner than the other), non-continuous 
deposition of thrombus, local bulging and multiple regi-
ons where the wall is adjacent to thin thrombus throug-
hout AAA development.
For both levels of activity within the luminal layer, a 
second peak of MMP activity and expansion rate was 
observed due to an increase in proteases from a develo-
ping vasa vasorum driven (in this model) by elastin de-
gradation products. Interestingly, this second MMP peak 
is greater in the model with a lower luminal activity even 
though the expansion rate is lower.
As expected, note from Figure 8 (a) and (d) that the si-
mulated AAA was larger after 20 years in the case of a 
high proteolytic activity (5.5 cm vs. 4.5 cm in outer dia-
meter). Yet, there is no indication that thrombus thickne-
ss is directly responsible for AAA rupture as seen from 
simulations in previous sections where ruptures occurred 
in both small and large aneurysms, and some large ane-
urysms (11cm) remained stable. Further finite element 
analyses are warranted for confirmation, but we do not 
expect ILT thickness or other simple measures of ILT 
size to enable rupture predictions directly.
Conclusion
The field of computational biomechanics is increasingly 
used to investigate complex processes in vascular health 
and disease. Prior G&R models of aortic aneurysms (cf. 
[11,12]) have provided considerable insight that comple-
ment histopathological studies and clinical observations, 
Fig. 7. Evolution of AAAs from an initially normotensive 
following development of stage 3 hypertension at different times 
during AAA progression. “x” denotes rupture.
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but have heretofore failed to include the biochemomec-
hanical effects of intraluminal thrombus on the aneu-
rysmal wall. We consider these effects to be fundamental 
to the evolution of this disease and therefore for predi-
cting clinical outcomes related to AAA enlargement and 
rupture. The current model was developed using a cylin-
drical geometry in order to focus on the importance of 
different constitutive assumptions and ranges of parame-
ter values before introducing complex geometric effects 
that arise with local bulging. Clearly, such effects requ-
ire investigation in future studies; nevertheless, this ini-
tial simplification yielded new insights into both the 
important roles that ILT may play during the evolution 
of aneurysms and the potential roles of diverse risk and 
stabilization factors.
While it appears that stiffening of collagen may increase 
the chances of stabilizing an aneurysm, it might not be 
sufficient. Inhibition of elastase activity could be impor-
tant in preventing rupture, particularly since elastin de-
gradation products can drive further inflammation and 
matrix loss. The simulations further suggested that an 
ILT can significantly influence AAA expansion and rup-
ture risk. Notably, high proteolytic activity in the luminal 
layer of the thrombus may increase expansion rate and 
rupture risk when in close proximity to the remodeling 
wall (i.e., a thin thrombus), and the evolving ILT may 
contribute to clinically observed discontinuous expansi-
on patterns. We conclude, therefore, that ILT should not 
be neglected in future experimental and computational 
models.
Despite the geometric limitation and inability to capture 
complexities such as eccentric thrombus or local 
non-axisymmetric bulging of the lesion, the basic results 
were largely consistent with clinical observations, intu-
ition, and previous computational G&R models having 
more complex geometries but without thrombus. Simu-
lations yielded average rates of expansion of around 2 
mm/year, whereas rapid expansion (1-2 cm/year) led to 
rupture. Smoking increased expansion rates by ~0.050 
cm/year, and hypertension increased expansion by 
~0.022 cm/year per 10 mmHg, both of which are clini-
cally observed [33]. The model confirms and offers ad-
Fig. 8. Evolution of radius, MMPs, and expansion rate for AAAs with low proteolytic activity in the luminal layer of ILT (a-c) versus 
high proteolytic activity (d-f). (a,d) Evolution of radius at the ILT/wall interface (solid line) and luminal layer/wall or medial layer in-
terface (dashed line). (b,e) Evolution of the normalized total amount of MMPs in the wall (solid line) and intima (dashed line). (c.f) 
Evolution of expansion rate.
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ditional support to female gender, smoking, and hyper-
tension being factors that increase rupture-risk.
Given the understanding gleaned from this simple geo-
metric model, there is now a need to move toward more 
complex (axisymmetric, non-axisymmetric and pa-
tient-specific) geometries with axially and circumferen-
tially variable thrombus thickness (i.e., shoulder regions 
and eccentric thrombus). In order to assess the effects of 
spatially heterogeneous weakening in regions with thin 
thrombus and mechanical shielding in regions with thic-
ker thrombus. Indeed, full fluid-solid-growth models 
would be ideal [58], as ILT formation and growth are 
strongly influenced by hemodynamics. In conclusion, 
we suggest that a careful consideration of the mechani-
cal, chemical, and biological influences of proteolytica-
lly active, multi-layered intraluminal thrombus on AAA 
development will be required to maximize the potential 
for identifying and ameliorating rupture-risk factors (or, 
equally important, promoting stabilization factors), pro-
viding patient-specific diagnostics and interventional 
planning, and ultimately improving clinical outcomes.
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